Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

11.8%

2 terminated out of 17 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (7)
P 1 (4)
P 2 (2)
P 3 (1)

Trial Status

Completed6
Unknown4
Recruiting3
Terminated2
Active Not Recruiting1
Withdrawn1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT04244877Phase 3Withdrawn

Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility

NCT04208828RecruitingPrimary

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

NCT05989763Not ApplicableRecruiting

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

NCT06631001Not ApplicableRecruiting

"The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving Enteral Nutrition in Intensive Care"

NCT06347367Not ApplicableActive Not Recruiting

Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention

NCT05268328Unknown

The Effect of Foot Reflexology After Cesarean Section

NCT04764019Not ApplicableUnknownPrimary

Intestinal Dysmotility in Patients With Functional Digestive Symptoms

NCT04429802Not ApplicableCompletedPrimary

The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity

NCT04988438UnknownPrimary

Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19

NCT03552510Not ApplicableCompleted

Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility

NCT03012594Phase 2CompletedPrimary

Lanreotide in the Treatment of Small Bowel Motility Disorders

NCT02573519Not ApplicableTerminated

Gastrointestinal Motility Among Diabetes Patients

NCT01644240Phase 1TerminatedPrimary

A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects

NCT01394055Phase 1Completed

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

NCT02245165Phase 1CompletedPrimary

Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

NCT01635608Phase 1CompletedPrimary

Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water

NCT00793195Phase 2Unknown

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

Showing all 17 trials

Research Network

Activity Timeline